Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium

EBioMedicine

Volumn 2, Issue 11, 2015, Pages 1677-1685

  Huang, Ruyi ^a,b   Wei, Yongyue ^a,af   Hung, Rayjean J ^c   Liu, Geoffrey ^d   Su, Li ^a   Zhang, Ruyang ^a,af   Zong, Xuchen ^c   Zhang, Zuo Feng ^e   Morgenstern, Hal ^f   Brüske, Irene ^g   Heinrich, Joachim ^g   Hong, Yun Chul ^h   Kim, Jin Hee ⁱ   Cote, Michele ^j   Wenzlaff, Angela ^j   Schwartz, Ann G ^j   Stucker, Isabelle ^k   Mclaughlin, John ^l   Marcus, Michael W ^m   Davies, Michael P A ^m   Liloglou, Triantafillos ^m   Field, John K ^m   Matsuo, Keitaro ⁿ   Barnett, Matt ^o   Thornquist, Mark ^o   Goodman, Gary ^o   Wang, Yi ^p,q   Chen, Size ^p,r   Yang, Ping ^p   Duell, Eric J ^s   Andrew, Angeline S ^t   Lazarus, Philip ^u   Muscat, Joshua ^u   Woll, Penella ^v   Horsman, Janet ^v   Dawn Teare, M ^v   Flugelman, Anath ^w   Rennert, Gad ^w   Zhang, Yan ^x   Brenner, Hermann ^x   Stegmaier, Christa ^y   van der Heijden, Erik H F M ^z   Aben, Katja ^z,aa   Kiemeney, Lambertus ^z   Barros Dios, Juan ^ab   Pérez Ríos, Monica ^ab   Ruano Ravina, Alberto ^ab   Caporaso, Neil E ^ac   Bertazzi, Pier Alberto ^ad,ae   Landi, Maria Teresa ^ad,ae   Dai, Juncheng ^af   Shen, Hongbing ^af   Fernandez Tardon, Guillermo ^ag   Rodriguez Suarez, Marta ^ah   Tardon, Adonina ^ag   Christiani, David C ^a,af,ai   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b E DA HOSPITAL   (Taiwan)

^c MOUNT SINAI HOSPITAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h Seoul National University College of Medicine   (South Korea)

ⁱ Seoul National University   (South Korea)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k INSERM   (France)

^l PUBLIC HEALTH ONTARIO   (Canada)

^m UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁿ AICHI CANCER CENTER HOSPITAL   (Japan)

^o Fred Hutchinson Cancer Research Center   (United States)

^p MAYO CLINIC   (United States)

^q WENZHOU MEDICAL UNIVERSITY   (China)

^r GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^s CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^t DARTMOUTH MEDICAL SCHOOL   (United States)

^u PENN STATE COLLEGE OF MEDICINE   (United States)

^v UNIVERSITY OF SHEFFIELD   (United Kingdom)

^w CARMEL MEDICAL CENTER   (Israel)

^x GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^y Saarland Cancer Registry   (Germany)

^z RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^aa Netherlands Comprehensive Cancer Organization   (Netherlands)

^ab HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^ac NATIONAL CANCER INSTITUTE   (United States)

^ad FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^ae UNIVERSITY OF MILAN   (Italy)

^af NANJING MEDICAL UNIVERSITY   (China)

^ag UNIVERSITY OF OVIEDO   (Spain)

^ah DEPARTMENT OF CONSERVATION BIOLOGY   (Spain)

^ai MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Causal mediation analysis; Chronic obstructive pulmonary disease; Multicenter pooling; Small cell lung cancer risk; Smoking behaviors

Indexed keywords

ADULT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FAMILY HISTORY; FEMALE; HUMAN; LIBRARY SCIENCE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; SMOKING; SMOKING CESSATION; ADVERSE EFFECTS; AGED; BIOLOGICAL MODEL; CASE CONTROL STUDY; COMPLICATION; HEALTH SURVEY; LUNG NEOPLASMS; MIDDLE AGED; ODDS RATIO; RISK; SMALL CELL LUNG CARCINOMA; TIME FACTOR;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ODDS RATIO; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SMALL CELL LUNG CARCINOMA; SMOKING; TIME FACTORS;

EID: 84958846161     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.09.031     Document Type: Article

References (71)

1. Armstrong B.G., Sloan M. Ordinal regression models for epidemiologic data. Am. J. Epidemiol. 1989, 129(1):191-204.
2. Ballaz S., Mulshine J.L. The potential contributions of chronic inflammation to lung carcinogenesis. Clin. Lung Cancer 2003, 5(1):46-62.
3. Barr R.G., Herbstman J., Speizer F.E., Camargo C.A. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am. J. Epidemiol. 2002, 155(10):965-971.
4. Bednarek M., Maciejewski J., Wozniak M., Kuca P., Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008, 63(5):402-407.
5. Brenner D.R., Hung R.J., Tsao M.S., et al. Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer 2010, 10:285.
6. Campbell I. Usefulness of generalized additive models. Stat. Methods Med. Res. 1996, 5(3):331-332.
7. Conway M.R. A random effects model for binary data. Biometrics 1990, 46:317-328.
8. Cote M.L., Liu M., Bonassi S., et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur. J. Cancer 2012, 48(13):1957-1968.
9. Eisner M.D., Trupin L., Katz P.P., et al. Development and validation of a survey-based COPD Severity Score. Chest 2005, 127(6):1890-1897.
10. Engeland A., Haldorsen T., Andersen A., Tretli S. The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women. Cancer Causes Control 1996, 7(3):366-376.
11. Etzel C.J., Lu M., Merriman K., Liu M., Vaporciyan A., Spitz M.R. An epidemiologic study of early onset lung cancer. Lung Cancer 2006, 52(2):129-134.
12. Fan Y.G., Jiang Y., Chang R.S., et al. Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. Lung Cancer 2011, 72(2):258-263.
13. Field J.K., Smith D.L., Duffy S., Cassidy A. The Liverpool Lung Project Research protocol. Int. J. Oncol. 2005, 27(6):1633-1645.
14. Freedman N.D., Leitzmann M.F., Hollenbeck A.R., Schatzkin A., Abnet C.C. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008, 9(7):649-656.
15. Fruh M., De Ruysscher D., Popat S., Crino L., Peters S., Felip E. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013, 24(Suppl. 6):vi99-v105.
16. van Gestel Y.R., Hoeks S.E., Sin D.D., et al. COPD and cancer mortality: the influence of statins. Thorax 2009, 64(11):963-967.
17. Goodman G.E., Valanis B., Meyskens F.L., et al. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-carotene and retinol efficacy trial. Cancer Epidemiol. Biomark. Prev. 1998, 7(5):405-412.
18. Hashibe M., Morgenstern H., Cui Y., et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol. Biomark. Prev. 2006, 15(10):1829-1834.
19. Hastie T., Tibshirani R. Generalized additive models for medical research. Stat. Methods Med. Res. 1995, 4(3):187-196.
20. Heck J.E., Andrew A.S., Onega T., et al. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 2009, 117(11):1718-1723.
21. Houghton A.M. Mechanistic links between COPD and lung cancer. Nat. Rev. Cancer 2013, 13(4):233-245.
22. Houtmeyers E., Gosselink R., Gayan-Ramirez G., Decramer M. Regulation of mucociliary clearance in health and disease. Eur. Respir. J. 1999, 13(5):1177-1188.
23. Hung R.J., Christiani D.C., Risch A., et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol. Biomark. Prev. 2008, 17(11):3081-3089.
24. Ito H., McKay J.D., Hosono S., et al. Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population. J. Thorac. Oncol. 2012, 7(5):790-798.
25. Janda S., Park K., FitzGerald J.M., Etminan M., Swiston J. Statins in COPD: a systematic review. Chest 2009, 136(3):734-743.
26. Kalemkerian G.P., Akerley W., Bogner P., et al. Small cell lung cancer. J. Natl. Compr. Cancer Netw. 2013, 11(1):78-98.
27. Kato K., Kiyokawa T., Mori K., et al. Current state of treatment for advanced gastric cancer. Gan To Kagaku Ryoho 2011, 38(2):184-186.
28. Kew K.M., Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014, 3:CD010115.
29. Kim J.H., Hong Y.C. No association between tumor necrosis factor-alpha gene polymorphisms and lung cancer risk. Environ. Health Toxicol. 2013, 28.
30. Kreienbrock L., Kreuzer M., Gerken M., et al. Case-control study on lung cancer and residential radon in Western Germany. Am. J. Epidemiol. 2001, 153(1):42-52.
31. Lamprecht B., Soriano J.B., Studnicka M., et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest 2015.
32. Landi M.T., Consonni D., Rotunno M., et al. Environment and genetics in lung cancer etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 2008, 8:203.
33. Lee C.H., Hyun M.K., Jang E.J., Lee N.R., Kim K., Yim J.J. Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer. Respir. Med. 2013, 107(8):1222-1233.
34. Lee S.M., Woll P.J., Rudd R., et al. Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J. Natl. Cancer Inst. 2009, 101(15):1049-1057.
35. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327(5965):542-545.
36. Liu X., Engelhardt J.F. The glandular stem/progenitor cell niche in airway development and repair. Proc. Am. Thorac. Soc. 2008, 5(6):682-688.
37. Liu H., Kho A.T., Kohane I.S., Sun Y. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med. 2006, 3(7).
38. Lopez-Cima M.F., Alvarez-Avellon S.M., Pascual T., Fernandez-Somoano A., Tardon A. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias. BMC Cancer 2012, 12:433.
39. Loriot M.A., Rebuissou S., Oscarson M., et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics 2001, 11(1):39-44.
40. Luce D., Stucker I. Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France. BMC Public Health 2011, 11:928.
41. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2000, 160(11):1683-1689.
42. Miller D.P., Liu G., De Vivo I., et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res. 2002, 62(10):2819-2823.
43. Murgia N., Brisman J., Claesson A., Muzi G., Olin A.C., Toren K. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulm. Med. 2014, 14:49.
44. Muscat J.E., Stellman S.D., Wynder E.L. Insulation, asbestos, smoking habits, and lung cancer cell types. Am. J. Ind. Med. 1995, 27(2):257-269.
45. Parimon T., Chien J.W., Bryson C.L., McDonell M.B., Udris E.M., Au D.H. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007, 175(7):712-719.
46. Park J.Y., Chen L., Elahi A., Lazarus P., Tockman M.S. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. Eur. J. Cancer Prev. 2005, 14(3):223-230.
47. Pesch B., Kendzia B., Gustavsson P., et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int. J. Cancer 2012, 131(5):1210-1219.
48. Pruefer D., Makowski J., Schnell M., et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002, 106(16):2104-2110.
49. Purdue M.P., Gold L., Jarvholm B., Alavanja M.C., Ward M.H., Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007, 62(1):51-56.
50. Raviv S., Hawkins K.A., DeCamp M.M., Kalhan R. Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am. J. Respir. Crit. Care Med. 2011, 183(9):1138-1146.
51. Roca M., Roca I.C., Mihaescu T. Lung cancer - a comorbidity in chronic obstructive pulmonary disease. Rev. Med. Chir. Soc. Med. Nat. Iasi 2012, 116(4):1055-1062.
52. Ruano-Ravina A., Figueiras A., Barros-Dios J.M. Type of wine and risk of lung cancer: a case-control study in Spain. Thorax 2004, 59(11):981-985.
53. Ruano-Ravina A., Pereyra M.F., Castro M.T., Perez-Rios M., Abal-Arca J., Barros-Dios J.M. Genetic susceptibility, residential radon, and lung cancer in a radon prone area. J. Thorac. Oncol. 2014, 9(8):1073-1080.
54. Schottker B., Haug U., Schomburg L., et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am. J. Clin. Nutr. 2013, 97(4):782-793.
55. Schwartz A.G., Ruckdeschel J.C. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173(1):16-22.
56. Schwartz A.G., Cote M.L., Wenzlaff A.S., Land S., Amos C.I. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J. Thorac. Oncol. 2009, 4(10):1195-1201.
57. Sevilya Z., Leitner-Dagan Y., Pinchev M., et al. Low integrated DNA repair score and lung cancer risk. Cancer Prev. Res. (Phila.) 2014, 7(4):398-406.
58. St Sauver J.L., Grossardt B.R., Leibson C.L., Yawn B.P., Melton L.J., Rocca W.A. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin. Proc. 2012, 87(2):151-160.
59. Stang A., Pohlabeln H., Muller K.M., Jahn I., Giersiepen K., Jockel K.H. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer 2006, 52(1):29-36.
60. Straus S.E., McAlister F.A., Sackett D.L., Deeks J.J. Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. J. Gen. Intern. Med. 2002, 17(9):684-688.
61. Thorley A.J., Tetley T.D. Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulm. Dis. 2007, 2(4):409-428.
62. VanderWeele T.J., Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am. J. Epidemiol. 2010, 172(12):1339-1348.
63. VanderWeele T.J., Asomaning K., Tchetgen Tchetgen E.J., et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am. J. Epidemiol. 2012, 175(10):1013-1020.
64. Vineis P., Kogevinas M., Simonato L., Brennan P., Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat. Res. 2000, 463(1):103-110.
65. Wang Y., McKay J.D., Rafnar T., et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat. Genet. 2014, 46(7):736-741.
66. Wang J., Spitz M.R., Amos C.I., Wilkinson A.V., Wu X., Shete S. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 2010, 116(14):3458-3462.
67. Yang P., Allen M.S., Aubry M.C., et al. Clinical features of 5628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005, 128(1):452-462.
68. Young R.P., Hopkins R.J. How the genetics of lung cancer may overlap with COPD. Respirology 2011, 16(7):1047-1055.
69. Zhai R., Yu X., Shafer A., Wain J.C., Christiani D.C. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest 2014, 145(2):346-353.
70. Zhai R., Yu X., Wei Y., Su L., Christiani D.C. Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease. Int. J. Cancer 2014, 134(4):961-970.
71. Zhang M., Hu Z., Huang J., et al. A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population. Clin. Cancer Res. 2010, 16(4):1236-1244.